Tokyo, April 12 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000061233) titled 'beta-trace protein concentrations in cerebrospinal fluid and epidural aspirates: a prospective observational study' on April 12.
Study Type:
Observational
Primary Sponsor:
Institute - University of the Ryukyus Hospital
Condition:
Condition - Differentiation of cerebrospinal fluid and epidural fluid
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - To evaluate the diagnostic utility of beta-trace protein (BTP) for distinguishing cerebrospinal fluid from epidural fluid.
Basic objectives2 - Efficacy
Eligibility:
Age-lower limit - 20
years-old
=
Gender - Male and Female
Key inclusion criteria - Patients aged 20 to 75 years with American Society of Anesthesiologists physical status I or II who were scheduled to undergo elective surgery under general anesthesia with epidural analgesia or spinal anesthesia, and from whom epidural aspirates or cerebrospinal fluid samples could be collected for analysis.
Key exclusion criteria - Patients who did not meet the inclusion criteria, those in whom epidural aspirates or cerebrospinal fluid samples could not be obtained, and those judged by the investigators to be inappropriate for participation.
Target Size - 80
Recruitment Status:
Recruitment status - Completed
Date of protocol fixation - 2019 Year 11 Month 01 Day
Date of IRB - 2019 Year 11 Month 01 Day
Anticipated trial start date - 2019 Year 11 Month 11 Day
Last follow-up date - 2020 Year 04 Month 30 Day
To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000070072
Disclaimer: Curated by HT Syndication.
